Yu Mi Kang, M.D., PH.D., M.P.H.
NPI 1538621834 · Endocrinology, Diabetes & Metabolism Physician · Boston, MA
Enrolled with Medicare as Practitioner - Endocrinology · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Yu Mi Kang, M.D., PH.D., M.P.H. is a Endocrinology, Diabetes & Metabolism Physician provider in Boston, MA (NPI 1538621834).
Provider details
- NPI number
- 1538621834
- Entity type
- Individual
- Primary specialty
- Endocrinology, Diabetes & Metabolism PhysicianAllopathic & Osteopathic Physicians
- Credential
- M.D., PH.D., M.P.H.
- Sex
- Female
- Sole proprietor
- No
- License
- 292673 (MA)
Specialties & taxonomies
Allopathic & Osteopathic Physicians
Allopathic & Osteopathic Physicians
Allopathic & Osteopathic Physicians
Allopathic & Osteopathic Physicians
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure33% of score
7 yrs in NPPES registry
- Profile completeness33% of score
100% of core fields populated
- Practice footprint20% of score
1 documented practice location
- Open Payments transparency13% of score
Has Open Payments disclosures (2024)
Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our methodology.
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 5 distinct drugs on file.
| Drug | Part D claims (2024) |
|---|---|
| Pen Needle, Diabeticbrand: Ultra-Fine Short Pen Needle | 17 |
| Levothyroxine Sodium | 16 |
| Insulin Glargine,hum.rec.anlogbrand: Basaglar Kwikpen U-100 | 12 |
| Hydrocortisone | 11 |
| Metformin Hcl | 11 |
Medicare Part D only. These counts cover prescriptions paid through Medicare Part D in 2024 — they do notinclude cash-pay, commercial-insurance, Medicaid, or Part B–administered drugs, and badly undercount high cash-pay categories (e.g. GLP-1 weight-loss, testosterone, and ED medications). Any drug with 10 or fewer claims is omitted by CMS, and beneficiary counts under 11 are suppressed — so a missing drug means no Part D record, never zero. This is a factual claims summary, not an endorsement, not medical advice, and not a consumer report. Source: CMS Medicare Part D Prescribers — by Provider and Drug.
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$124 across 1 record (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Registry dates
- Enumerated
- 2019-04-04
- Last updated
- 2026-02-10
- Certified
- 2026-02-10
Frequently asked questions
- What is Yu Mi Kang's NPI number?
- Yu Mi Kang's National Provider Identifier (NPI) is 1538621834, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
- What is Yu Mi Kang's specialty?
- Yu Mi Kang is listed in the NPPES registry with a primary specialty of Endocrinology, Diabetes & Metabolism Physician (Allopathic & Osteopathic Physicians).
- Where is Yu Mi Kang located?
- Yu Mi Kang's practice location on file with NPPES is 221 Longwood Ave Fl 2, Boston, MA 02115-5817.
- What is Yu Mi Kang's phone number?
- The practice phone number listed in the NPPES registry for Yu Mi Kang is (617) 732-5666.
- Does Yu Mi Kang accept Medicare?
- Yu Mi Kang is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
- Is Yu Mi Kang's NPI active?
- Yes — Yu Mi Kang's NPI (1538621834) is active in the NPPES registry as of the last update on 2026-02-10.
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.